loading

Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.20%
9.626
9.419 7.357 6.845 8.533
Operating Expenses
7.02%
20.72
19.36 18.89 17.80 20.74
Benefits Costs and Expenses
8.70%
19.82
18.24 17.77 16.46 19.28
Costs And Expenses
8.70%
19.82
18.24 17.77 16.46 19.28
Operating Income/Loss
11.59%
-11.09
-9.941 -11.53 -10.96 -12.20
Nonoperating Income/Loss
20.30%
0.895
1.123 1.121 1.343 1.457
Income/Loss From Continuing Operations Before Tax
15.65%
-10.20
-8.818 -10.41 -9.613 -10.75
Income Tax Expense/Benefit
-
- -0.076 - 0.406
Income/Loss From Continuing Operations After Tax
15.65%
-10.20
-8.818 -10.34 -9.613 -11.15
Net Income/Loss
15.65%
-10.20
-8.818 -10.34 -9.613 -11.15
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.99%
7.6559
7.5063 0.1768 6.3514 5.6428
Diluted Average Shares
1.99%
7.6559
7.5063 0.1768 6.3514 5.6428
Basic Earnings Per Share
13.68%
-1.33
-1.17 -1.57 -1.51 -1.98
Diluted Earnings Per Share
13.68%
-1.33
-1.17 -1.57 -1.51 -1.98
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.07
price up icon 1.07%
$84.09
price down icon 0.61%
$25.23
price up icon 1.49%
$102.39
price down icon 0.60%
$135.63
price up icon 0.85%
biotechnology ONC
$299.23
price down icon 0.29%
Kapitalisierung:     |  Volumen (24h):